Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.

IF 19.3 1区 医学 Q1 MICROBIOLOGY
Rémy A Bonnin,Agnès B Jousset,Aymeric Jacquemin,Cécile Emeraud,Delphine Girlich,Thierry Naas,Laurent Dortet
{"title":"Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.","authors":"Rémy A Bonnin,Agnès B Jousset,Aymeric Jacquemin,Cécile Emeraud,Delphine Girlich,Thierry Naas,Laurent Dortet","doi":"10.1128/cmr.00129-23","DOIUrl":null,"url":null,"abstract":"SUMMARYMetallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"27 1","pages":"e0012923"},"PeriodicalIF":19.3000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/cmr.00129-23","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

SUMMARYMetallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.
IMP型和vim型碳青霉烯酶的遗传多样性、生化特性、流行病学及检测方法。
金属-内酰胺酶是一个日益严重的问题。自20世纪60年代末蜡样芽孢杆菌的β -内酰胺酶被发现以来,已报道了许多B类β -内酰胺酶,主要有NDM-、IMP-和VIM-like三个家族。IMP-和vim样碳青霉烯酶已在多种革兰氏阴性菌中发现。vim型碳青霉烯酶分布广泛,主要以VIM-1和VIM-2两个主要簇为代表,在肠杆菌和非发酵菌中均有发现。imp型碳青霉烯酶具有显著的遗传多样性和亚群之间的低同一性。这种碳青霉烯酶在亚洲更为普遍,但在全球范围内已被发现,在肠杆菌和非发酵菌中都有发现,如在vim型碳青霉烯酶中观察到的那样。IMP-和一些vim型碳青霉烯酶的遗传多样性限制了它们的检测。本文综述了VIM型和imp型碳青霉烯酶的遗传多样性、流行病学和生化特性。它还评估了市售检测试验的功效和最近开发的抑制剂的体外活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Microbiology Reviews
Clinical Microbiology Reviews 医学-微生物学
CiteScore
54.20
自引率
0.50%
发文量
38
期刊介绍: Clinical Microbiology Reviews (CMR) is a journal that primarily focuses on clinical microbiology and immunology.It aims to provide readers with up-to-date information on the latest developments in these fields.CMR also presents the current state of knowledge in clinical microbiology and immunology.Additionally, the journal offers balanced and thought-provoking perspectives on controversial issues in these areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信